entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 04:24:27 - browse：775

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： HIV drugs protect against transmission, even in unprotected sex

WSS

Letters to First Opinion on caregivers, digital health, and more

Doctor of U.S. President Joe Biden says he is fit for duty

Redefining sustainability for the pharmaceutical industry

Innovation in antibiotics is ailing. 'Brain drain' may kill it

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

leisure time

entertainment

hotspot

Apple is now the first public company to be valued at $3 trillion

How to increase colonoscopy rates? Looks like an AI can help

Duchenne breakthrough therapy leaves behind pioneering families

Intellia reports positive results for its CRISPR

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Using force crossed my mind when examining a defiant young patient

FDA approval of Sarepta Duchenne genetic therapy gives me hope

See how much Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

hotspot

BMI, flaws aside, is found to be useful estimate of body fat in youth

Elisabeth Bik tackles the widespread issue of research misconduct

Cholera vaccine supplies dangerously low, outbreaks surging

FDA's Pazdur wants cancer trials to range beyond China alone

ASCO: AstraZeneca says CAR

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

focus

focus

hotspot

leisure time